Transition-specific event rates by anemia and renal impairment, N = 6029.

Frequencies and percentages of patients in each stage of kidney disease before and after contrast administration, as determined by estimated glomerular filtration rates.

Joao Italo Fortalesa Melo (737121)
Rubens Chojniak (598260)
Debora Helena Costa Silva (737122)
Jose Carlos Oliveira Junior (737123)
Almir Galvão Vieira Bitencourt (737124)
Diego Holanda Silva (737125)
Marcos Duarte Guimarães (598263)
Hernandes Cerqueira Souza Silva (737126)
Denis Guilherme Teixeira Dias (737127)
Winglison Carli Rodrigues (737128)
Ellen Luzia Brancucci (737129)
Barbara Martins Soares Cruz (737130)
Beatriz Nunes Schiavon (737131)
Juliana Luz Passos Argenton (737132)
Margareth Arrivabene Camporini (737133)
Adriana Zocchio (737134)

May 2015

Data are presented as n (%). GFRs are in ml/min/1.73m2.Stage 1 = kidney ...

Predicted probabilities and 95% CI.

Thomas Pilgrim (339922)
Martina Rothenbühler (672060)
Bindu Kalesan (625379)
Cédric Pulver (672061)
Giulio G. Stefanini (625377)
Thomas Zanchin (672062)
Lorenz Räber (543629)
Stefan Stortecky (339925)
Simon Jung (672063)
Heinrich Mattle (672064)
Aris Moschovitis (672065)
Peter Wenaweser (339923)
Bernhard Meier (95663)
Thomas Gsponer (383441)
Stephan Windecker (95664)
Peter Jüni (50488)

December 2014

Reference category: No anemia and no renal impairment.Displayed numbers in column 2–5 repr...

Acute kidney injury (AKI) event rate according to genotype; three-class classification.

Laura M. Vilander (6729845)
Suvi T. Vaara (2504209)
Kati M. Donner (6729848)
Päivi Lakkisto (223353)
Mari A. Kaunisto (207090)
Ville Pettilä (2504218)

May 2019

Allele lengths are: S 2 ≥34. The blue columns each illustrate the event rate within a genotype, wher...

Level of stunting and anemia (n = 328): relative frequencies (%), absolute frequencies (n) and confidence intervals of 95% (IC95%).

Dinamene Oliveira (796151)
Filipa Santana Ferreira (796152)
Jorge Atouguia (746032)
Filomeno Fortes (305927)
António Guerra (763175)
Sónia Centeno-Lima (796153)

September 2015

Level of stunting and anemia (n = 328): relative frequencies (%), absolute frequencies (n) and co...

illustrates proportions of events up to four years according to anemia and renal impairment at baseline.

Thomas Pilgrim (339922)
Martina Rothenbühler (672060)
Bindu Kalesan (625379)
Cédric Pulver (672061)
Giulio G. Stefanini (625377)
Thomas Zanchin (672062)
Lorenz Räber (543629)
Stefan Stortecky (339925)
Simon Jung (672063)
Heinrich Mattle (672064)
Aris Moschovitis (672065)
Peter Wenaweser (339923)
Bernhard Meier (95663)
Thomas Gsponer (383441)
Stephan Windecker (95664)
Peter Jüni (50488)

December 2014

illustrates proportions of events up to four years according to anemia and renal impairment at ba...

shows the transition-specific adjusted hazard ratios with 95% CI according to anemia and renal impairment using Cox proportional hazard models within a multi-state analysis.

Thomas Pilgrim (339922)
Martina Rothenbühler (672060)
Bindu Kalesan (625379)
Cédric Pulver (672061)
Giulio G. Stefanini (625377)
Thomas Zanchin (672062)
Lorenz Räber (543629)
Stefan Stortecky (339925)
Simon Jung (672063)
Heinrich Mattle (672064)
Aris Moschovitis (672065)
Peter Wenaweser (339923)
Bernhard Meier (95663)
Thomas Gsponer (383441)
Stephan Windecker (95664)
Peter Jüni (50488)

December 2014

Adjustment for type of stent, age, gender, diabetes, hypertension, dyslipidemia, LV function, acu...

Number of outcome events in each study group by phosphate range in; the total population (N = 57,832), those with normal renal function (N = 24,184), those with CKD stages 1–2 (N = 20,356), and those with CKD stages 3–5 (N = 13,292) where phosphate measurements were available.

Andrew Peter McGovern (456786)
Simon de Lusignan (2416)
Jeremy van Vlymen (456787)
Harshana Liyanage (456788)
Charles Richard Tomson (456789)
Hugh Gallagher (456790)
Meena Rafiq (456791)
Simon Jones (26390)

September 2013

The percentages shown are the proportion of people within category who had a cardiovascular event...

Incidence of anemia among the various hemoglobin variants observed in the subjects.

Vital Glah Abuku (14328881)
Emmanuel Alote Allotey (14328884)
Maxwell Akonde (10205748)

January 2023

Incidence of anemia among the various hemoglobin variants observed in the subjects.</p

Prevalence of anemia.

Melissa E. Stauffer (505406)
Tao Fan (363653)

January 2014

The percentages reflect the prevalence of anemia, survey weighted to the US population. The analy...

Frequency of individuals (%) affected by anomalies/severe anomalies (in bold) in the different body regions. Empty cells indicate 0.0%. Organic lots are highlighted with grey background. VT = vertebrae.

Clara Boglione (284495)
Domitilla Pulcini (561588)
Michele Scardi (284500)
Elisa Palamara (284499)
Tommaso Russo (397627)
Stefano Cataudella (284501)

May 2014

Frequency of individuals (%) affected by anomalies/severe anomalies (in bold) in the different bo...

Laboratory markers associated with severe anaemia mechanisms.

Michaël Boele van Hensbroek (52384)
Job C. J. Calis (52378)
Kamija S. Phiri (52377)
Raymond Vet (361890)
Francis Munthali (361891)
Rob Kraaijenhagen (361892)
Henk van den Berg (316364)
Brian Faragher (52379)
Imelda Bates (205456)
Malcolm E. Molyneux (52383)

February 2013

# Defined by the presence of dyserythropoietic features in >2% of red cell precursors.*Med...

Comparisons of baseline demographics between the rapid renal function decline rate and the non-rapid renal function decline rate groups.

Chun-Cheng Wang (848196)
Ming-Yi Shen (197443)
Kuan-Cheng Chang (189170)
Guei-Jane Wang (640700)
Shu-Hui Liu (767953)
Chiz-Tzung Chang (388862)

May 2019

Comparisons of baseline demographics between the rapid renal function decline rate and the non-rapid...

Incidence and prevalence of anemia among patients with NDD-CKD in the EGB database per year (2015–2017).

Karim Dardim (16496517)
Jérôme Fernandes (4339828)
Arnaud Panes (16496520)
Julien Beisel (16496523)
Aurélie Schmidt (3666916)
Josephine Wolfram (16496526)
Lora Todorova (16496529)
Laurence Dubel (16496532)
Thierry Lobbedez (2579155)

July 2023

Incidence and prevalence of anemia among patients with NDD-CKD in the EGB database per year (2015–20...

Proportion of the sample that developed the kidney function decline by ABI categories.

Xuehong Dong (651213)
Dingting Wu (651214)
Chengfang Jia (651215)
Yu Ruan (651216)
Xiaocheng Feng (651217)
Guoxing Wang (181313)
Jun Liu (42548)
Yi Shen (152956)
Hong Li (20183)
Lianxi Li (429084)

October 2014

Proportion of the sample that developed the kidney function decline by ABI categories.</p

Crude and standardized incidence rates of vascular events per 1,000 person-years by event category, 2004–2015.

Mar Masiá (379461)
Sergio Padilla (379460)
José A. García (267402)
Javier García-Abellán (6640355)
Marta Fernández (2624797)
Ignacio Bernardino (6640358)
Marta Montero (2950611)
Joaquim Peraire (836982)
Berta Pernas (6640361)
Félix Gutiérrez (2624794)

April 2019

Crude and standardized incidence rates of vascular events per 1,000 person-years by event category, ...

Frequencies and percentages of patients in each stage of kidney disease before and after contrast administration, as determined by estimated glomerular filtration rates.

Joao Italo Fortalesa Melo (737121)
Rubens Chojniak (598260)
Debora Helena Costa Silva (737122)
Jose Carlos Oliveira Junior (737123)
Almir Galvão Vieira Bitencourt (737124)
Diego Holanda Silva (737125)
Marcos Duarte Guimarães (598263)
Hernandes Cerqueira Souza Silva (737126)
Denis Guilherme Teixeira Dias (737127)
Winglison Carli Rodrigues (737128)
Ellen Luzia Brancucci (737129)
Barbara Martins Soares Cruz (737130)
Beatriz Nunes Schiavon (737131)
Juliana Luz Passos Argenton (737132)
Margareth Arrivabene Camporini (737133)
Adriana Zocchio (737134)

May 2015

Data are presented as n (%). GFRs are in ml/min/1.73m2.Stage 1 = kidney ...

Predicted probabilities and 95% CI.

Thomas Pilgrim (339922)
Martina Rothenbühler (672060)
Bindu Kalesan (625379)
Cédric Pulver (672061)
Giulio G. Stefanini (625377)
Thomas Zanchin (672062)
Lorenz Räber (543629)
Stefan Stortecky (339925)
Simon Jung (672063)
Heinrich Mattle (672064)
Aris Moschovitis (672065)
Peter Wenaweser (339923)
Bernhard Meier (95663)
Thomas Gsponer (383441)
Stephan Windecker (95664)
Peter Jüni (50488)

December 2014

Reference category: No anemia and no renal impairment.Displayed numbers in column 2–5 repr...

Acute kidney injury (AKI) event rate according to genotype; three-class classification.

Laura M. Vilander (6729845)
Suvi T. Vaara (2504209)
Kati M. Donner (6729848)
Päivi Lakkisto (223353)
Mari A. Kaunisto (207090)
Ville Pettilä (2504218)

May 2019

Allele lengths are: S 2 ≥34. The blue columns each illustrate the event rate within a genotype, wher...

Level of stunting and anemia (n = 328): relative frequencies (%), absolute frequencies (n) and confidence intervals of 95% (IC95%).

Dinamene Oliveira (796151)
Filipa Santana Ferreira (796152)
Jorge Atouguia (746032)
Filomeno Fortes (305927)
António Guerra (763175)
Sónia Centeno-Lima (796153)

September 2015

Level of stunting and anemia (n = 328): relative frequencies (%), absolute frequencies (n) and co...

illustrates proportions of events up to four years according to anemia and renal impairment at baseline.

Thomas Pilgrim (339922)
Martina Rothenbühler (672060)
Bindu Kalesan (625379)
Cédric Pulver (672061)
Giulio G. Stefanini (625377)
Thomas Zanchin (672062)
Lorenz Räber (543629)
Stefan Stortecky (339925)
Simon Jung (672063)
Heinrich Mattle (672064)
Aris Moschovitis (672065)
Peter Wenaweser (339923)
Bernhard Meier (95663)
Thomas Gsponer (383441)
Stephan Windecker (95664)
Peter Jüni (50488)

December 2014

illustrates proportions of events up to four years according to anemia and renal impairment at ba...

shows the transition-specific adjusted hazard ratios with 95% CI according to anemia and renal impairment using Cox proportional hazard models within a multi-state analysis.

Thomas Pilgrim (339922)
Martina Rothenbühler (672060)
Bindu Kalesan (625379)
Cédric Pulver (672061)
Giulio G. Stefanini (625377)
Thomas Zanchin (672062)
Lorenz Räber (543629)
Stefan Stortecky (339925)
Simon Jung (672063)
Heinrich Mattle (672064)
Aris Moschovitis (672065)
Peter Wenaweser (339923)
Bernhard Meier (95663)
Thomas Gsponer (383441)
Stephan Windecker (95664)
Peter Jüni (50488)

December 2014

Adjustment for type of stent, age, gender, diabetes, hypertension, dyslipidemia, LV function, acu...

Number of outcome events in each study group by phosphate range in; the total population (N = 57,832), those with normal renal function (N = 24,184), those with CKD stages 1–2 (N = 20,356), and those with CKD stages 3–5 (N = 13,292) where phosphate measurements were available.

Andrew Peter McGovern (456786)
Simon de Lusignan (2416)
Jeremy van Vlymen (456787)
Harshana Liyanage (456788)
Charles Richard Tomson (456789)
Hugh Gallagher (456790)
Meena Rafiq (456791)
Simon Jones (26390)

September 2013

The percentages shown are the proportion of people within category who had a cardiovascular event...

Incidence of anemia among the various hemoglobin variants observed in the subjects.

Vital Glah Abuku (14328881)
Emmanuel Alote Allotey (14328884)
Maxwell Akonde (10205748)

January 2023

Incidence of anemia among the various hemoglobin variants observed in the subjects.</p

Prevalence of anemia.

Melissa E. Stauffer (505406)
Tao Fan (363653)

January 2014

The percentages reflect the prevalence of anemia, survey weighted to the US population. The analy...

Frequency of individuals (%) affected by anomalies/severe anomalies (in bold) in the different body regions. Empty cells indicate 0.0%. Organic lots are highlighted with grey background. VT = vertebrae.

Clara Boglione (284495)
Domitilla Pulcini (561588)
Michele Scardi (284500)
Elisa Palamara (284499)
Tommaso Russo (397627)
Stefano Cataudella (284501)

May 2014

Frequency of individuals (%) affected by anomalies/severe anomalies (in bold) in the different bo...

Laboratory markers associated with severe anaemia mechanisms.

Michaël Boele van Hensbroek (52384)
Job C. J. Calis (52378)
Kamija S. Phiri (52377)
Raymond Vet (361890)
Francis Munthali (361891)
Rob Kraaijenhagen (361892)
Henk van den Berg (316364)
Brian Faragher (52379)
Imelda Bates (205456)
Malcolm E. Molyneux (52383)

February 2013

# Defined by the presence of dyserythropoietic features in >2% of red cell precursors.*Med...

Comparisons of baseline demographics between the rapid renal function decline rate and the non-rapid renal function decline rate groups.

Chun-Cheng Wang (848196)
Ming-Yi Shen (197443)
Kuan-Cheng Chang (189170)
Guei-Jane Wang (640700)
Shu-Hui Liu (767953)
Chiz-Tzung Chang (388862)

May 2019

Comparisons of baseline demographics between the rapid renal function decline rate and the non-rapid...

Incidence and prevalence of anemia among patients with NDD-CKD in the EGB database per year (2015–2017).

Karim Dardim (16496517)
Jérôme Fernandes (4339828)
Arnaud Panes (16496520)
Julien Beisel (16496523)
Aurélie Schmidt (3666916)
Josephine Wolfram (16496526)
Lora Todorova (16496529)
Laurence Dubel (16496532)
Thierry Lobbedez (2579155)

July 2023

Incidence and prevalence of anemia among patients with NDD-CKD in the EGB database per year (2015–20...

Proportion of the sample that developed the kidney function decline by ABI categories.

Xuehong Dong (651213)
Dingting Wu (651214)
Chengfang Jia (651215)
Yu Ruan (651216)
Xiaocheng Feng (651217)
Guoxing Wang (181313)
Jun Liu (42548)
Yi Shen (152956)
Hong Li (20183)
Lianxi Li (429084)

October 2014

Proportion of the sample that developed the kidney function decline by ABI categories.</p

Crude and standardized incidence rates of vascular events per 1,000 person-years by event category, 2004–2015.

Mar Masiá (379461)
Sergio Padilla (379460)
José A. García (267402)
Javier García-Abellán (6640355)
Marta Fernández (2624797)
Ignacio Bernardino (6640358)
Marta Montero (2950611)
Joaquim Peraire (836982)
Berta Pernas (6640361)
Félix Gutiérrez (2624794)

April 2019

Crude and standardized incidence rates of vascular events per 1,000 person-years by event category, ...

Frequencies and percentages of patients in each stage of kidney disease before and after contrast administration, as determined by estimated glomerular filtration rates.

Joao Italo Fortalesa Melo (737121)
Rubens Chojniak (598260)
Debora Helena Costa Silva (737122)
Jose Carlos Oliveira Junior (737123)
Almir Galvão Vieira Bitencourt (737124)
Diego Holanda Silva (737125)
Marcos Duarte Guimarães (598263)
Hernandes Cerqueira Souza Silva (737126)
Denis Guilherme Teixeira Dias (737127)
Winglison Carli Rodrigues (737128)
Ellen Luzia Brancucci (737129)
Barbara Martins Soares Cruz (737130)
Beatriz Nunes Schiavon (737131)
Juliana Luz Passos Argenton (737132)
Margareth Arrivabene Camporini (737133)
Adriana Zocchio (737134)

May 2015

Data are presented as n (%). GFRs are in ml/min/1.73m2.Stage 1 = kidney ...

Predicted probabilities and 95% CI.

Thomas Pilgrim (339922)
Martina Rothenbühler (672060)
Bindu Kalesan (625379)
Cédric Pulver (672061)
Giulio G. Stefanini (625377)
Thomas Zanchin (672062)
Lorenz Räber (543629)
Stefan Stortecky (339925)
Simon Jung (672063)
Heinrich Mattle (672064)
Aris Moschovitis (672065)
Peter Wenaweser (339923)
Bernhard Meier (95663)
Thomas Gsponer (383441)
Stephan Windecker (95664)
Peter Jüni (50488)

December 2014

Reference category: No anemia and no renal impairment.Displayed numbers in column 2–5 repr...

Acute kidney injury (AKI) event rate according to genotype; three-class classification.

Laura M. Vilander (6729845)
Suvi T. Vaara (2504209)
Kati M. Donner (6729848)
Päivi Lakkisto (223353)
Mari A. Kaunisto (207090)
Ville Pettilä (2504218)

May 2019

Allele lengths are: S 2 ≥34. The blue columns each illustrate the event rate within a genotype, wher...

Transition-specific event rates by anemia and renal impairment, N = 6029.

Abstract

Extracted data

Transition-specific event rates by anemia and renal impairment, N = 6029.

Abstract

Extracted data

Related items

Related items